Finoriq research workspace
Gelteq Ltd (GELS) Historical Metrics
Gelteq Ltd offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as. Review GELS valuation ratios, fundamentals, and filing metrics on Finoriq.
Company Snapshot
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
- Company
- Gelteq Ltd (GELS)
- Ticker
- GELS
- Market Cap
- $6.2M
- Latest Price
- $0.5776
- Industry
- Biotech & Pharma
Gelteq Ltd (GELS) Current Valuation Metrics
Static valuation preview for Gelteq Ltd (GELS). Market data retrieved 2026-07-09. Filing currency AUD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 50.9x | Revenue | TTM FY 2025 |
| Earnings YieldLatest TTM net income divided by market cap. | -78.9% | Net Income | TTM FY 2025 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -65.5% | Operating Cash Flow | TTM FY 2025 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.